GSK plc

GLAXF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$3,693$2,936$3,723$4,274
Short-Term Investments$21$2,246$4,154$61
Receivables$5,999-$190$7,115$8,031
Inventory$5,669$5,498$5,146$5,783
Other Curr. Assets$1,615$8,154$7,946$8,756
Total Curr. Assets$16,997$18,644$20,769$18,674
Property Plant & Equip (Net)$10,073$9,957$9,620$10,672
Goodwill$6,982$6,811$7,046$10,552
Intangibles$15,515$14,768$14,318$30,079
Long-Term Investments$1,211$769-$2,613$2,153
Tax Assets$6,757$450$5,658$5,218
Other NC Assets$1,928$8,056$5,348$1,755
Total NC Assets$42,466$40,361$39,377$60,429
Other Assets$0$0$0$0
Total Assets$59,463$59,005$60,146$79,103
Liabilities
Payables$3,462$3,717$3,866$4,535
Short-Term Debt$2,349$2,813$3,952$3,601
Tax Payable$703$500$471$489
Deferred Revenue$0$0$1,306$1,557
Other Curr. Liab.$15,183$14,038$14,521$15,045
Total Curr. Liab.$21,697$21,068$22,810$23,670
LT Debt$14,637$15,205$17,035$20,572
Deferred Rev, NC$165$0$83$85
Deferred Tax Liab, NC$382$0$289$3,556
Other NC Liab.$9,496$9,937$10,205$9,878
Total NC Liab.$24,680$25,142$27,240$34,091
Other Liabilities$0$0$0$0
Cap. Leases$1,102$1,207$1,008$1,015
Total Liabilities$46,377$46,210$50,050$57,761
Equity
Pref Stock$0$0$48$0
Common Stock$1,348$1,348$1,347$1,347
Retained Earnings$7,796$7,239$4,363$7,944
AOCI$0$0-$48$0
Other Equity$4,527$4,760$4,888$5,764
Total Equity$13,671$13,347$10,598$15,055
Supplemental Information
Minority Interest-$585-$552-$502$6,287
Total Liab. & Tot. Equity$59,463$59,005$60,146$79,103
Net Debt$13,293$15,082$17,264$19,899
GSK plc (GLAXF) Financial Statements & Key Stats | AlphaPilot